CD80 and neoplasm: Flow cytometry results demonstrated that compared to the oe‐NC group, the oe‐NC+M2pep‐Cs NPs/Plerixafor group showed a significant increase in the M1 TAM marker CD80 in mouse tumor tissues, whereas the oe‐CXCR4 group showed a marked decrease.